Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Inmaculada Hernandez

Showing results (21-30 of 183) with videos related to

Pageof 19
Sort By:
Journal of Managed Care & Specialty Pharmacy|October 27, 2023
Nonfederal average manufacturer price to estimate savings generated by minimum discounts under the Inflation Reduction ActInmaculada Hernandez, Nico Gabriel, Sean Dickson
The American Journal of Cardiology|April 24, 2018
Effectiveness and Safety of Direct Oral Anticoagulants and Warfarin, Stratified by Stroke Risk in Patients With Atrial FibrillationInmaculada Hernandez, Yuting Zhang, Samir Saba
Drug and Alcohol Dependence|August 13, 2018
Comparing state, regional, and local variation in concurrent opioid and benzodiazepine useInmaculada Hernandez, Meiqi He, Yuting Zhang
The American Journal of Cardiology|September 3, 2017
Comparison of the Effectiveness and Safety of Apixaban, Dabigatran, Rivaroxaban, and Warfarin in Newly Diagnosed Atrial FibrillationInmaculada Hernandez, Yuting Zhang, Samir Saba
AIDS (London, England)|October 7, 2022
Estimated changes in price discounts for tenofovir-inclusive HIV treatments following introduction of tenofovir alafenamideSean Dickson, Nico Gabriel, Inmaculada Hernandez
Stroke|June 29, 2017
Geographic Variation in the Use of Oral Anticoagulation Therapy in Stroke Prevention in Atrial FibrillationInmaculada Hernandez, Samir Saba, Yuting Zhang
JAMA Health Forum|November 17, 2023
Trends in Proportion of Medicare Part D Claims Subject to 340B Discounts, 2013-2020Sean Dickson, Nico Gabriel, Inmaculada Hernandez
Thrombosis Research|October 25, 2016
Cost-effectiveness of non-vitamin K antagonist oral anticoagulants for stroke prevention in patients with atrial fibrillation at high risk of bleeding and normal kidney functionInmaculada Hernandez, Kenneth J Smith, Yuting Zhang
JAMA|May 22, 2024
Advancing Access to Cell and Gene Therapies in MedicaidJoseph T Kannarkat, Inmaculada Hernandez, Natasha Parekh
JAMA Network Open|February 20, 2020
Latent Classes of Adherence to Oral Anticoagulation Therapy Among Patients With a New Diagnosis of Atrial FibrillationNemin Chen, Maria M Brooks, Inmaculada Hernandez
Pageof 19

Showing results (21-30 of 183) with videos related to

Sort By:
Pageof 19
Journal of Managed Care & Specialty Pharmacy|October 27, 2023
Nonfederal average manufacturer price to estimate savings generated by minimum discounts under the Inflation Reduction ActInmaculada Hernandez, Nico Gabriel, Sean Dickson
The American Journal of Cardiology|April 24, 2018
Effectiveness and Safety of Direct Oral Anticoagulants and Warfarin, Stratified by Stroke Risk in Patients With Atrial FibrillationInmaculada Hernandez, Yuting Zhang, Samir Saba
Drug and Alcohol Dependence|August 13, 2018
Comparing state, regional, and local variation in concurrent opioid and benzodiazepine useInmaculada Hernandez, Meiqi He, Yuting Zhang
The American Journal of Cardiology|September 3, 2017
Comparison of the Effectiveness and Safety of Apixaban, Dabigatran, Rivaroxaban, and Warfarin in Newly Diagnosed Atrial FibrillationInmaculada Hernandez, Yuting Zhang, Samir Saba
AIDS (London, England)|October 7, 2022
Estimated changes in price discounts for tenofovir-inclusive HIV treatments following introduction of tenofovir alafenamideSean Dickson, Nico Gabriel, Inmaculada Hernandez
Stroke|June 29, 2017
Geographic Variation in the Use of Oral Anticoagulation Therapy in Stroke Prevention in Atrial FibrillationInmaculada Hernandez, Samir Saba, Yuting Zhang
JAMA Health Forum|November 17, 2023
Trends in Proportion of Medicare Part D Claims Subject to 340B Discounts, 2013-2020Sean Dickson, Nico Gabriel, Inmaculada Hernandez
Thrombosis Research|October 25, 2016
Cost-effectiveness of non-vitamin K antagonist oral anticoagulants for stroke prevention in patients with atrial fibrillation at high risk of bleeding and normal kidney functionInmaculada Hernandez, Kenneth J Smith, Yuting Zhang
JAMA|May 22, 2024
Advancing Access to Cell and Gene Therapies in MedicaidJoseph T Kannarkat, Inmaculada Hernandez, Natasha Parekh
JAMA Network Open|February 20, 2020
Latent Classes of Adherence to Oral Anticoagulation Therapy Among Patients With a New Diagnosis of Atrial FibrillationNemin Chen, Maria M Brooks, Inmaculada Hernandez
Pageof 19